Dialysis News and Research

Latest Dialysis News and Research

Study shows drama therapy improves mood and reduces pain for hemodialysis patients

For patients with kidney failure, getting creative may provide some relief. Kansas State University researchers are exploring the effects of drama therapy on patients undergoing chronic hemodialysis and are the first in the world to study the topic.

15 May 2013

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Armed with hefty federal loans, two startup health insurers are jumping into a crowded and confusing Oregon market just as the biggest changes to U.S. health care in generations roll out this fall.

15 May 2013

Children on dialysis for severe kidney disease have reduce risk of death

Children on dialysis for severe kidney disease have a dramatically reduced risk of death compared to 20 years ago, a new study shows. The findings, from a study led by Dr. Bethany Foster from the Research Institute of the McGill University Health Centre (RI-MUHC), are very encouraging for children with end-stage kidney disease.

10 May 2013

Study finds disparity in live-donor kidney transplants in African Americans

While the percentage of kidney transplants involving live donors has remained stable for other minority populations, African Americans have seen a decline in live donors even as more of them receive kidney transplants, according to a study by Henry Ford Hospital in Detroit.

9 May 2013

Study finds decrease in mortality rates among children initiating ESKD treatment with dialysis

In a study that included more than 20,000 patients, there was a significant decrease in the United States in mortality rates over time among children and adolescents initiating end-stage kidney disease treatment with dialysis between 1990 and 2010, according to a study in the May 8 issue of JAMA.

5 May 2013

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Merck & Co., Inc., known as MSD outside the United States and Canada, and Pfizer Inc. today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer's ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.

From Pfizer, Inc. 30 Apr 2013

Organic pollutants increase nephropathy risk in diabetes

Individuals with diabetes may reduce their risk for developing nephropathy if they minimize their exposure to persistent organic pollutants, suggest researchers.

29 Apr 2013

DaVita Hospital Services receives Ambulatory Health Care Accreditation

DaVita, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced that DaVita Hospital Services, the company's inpatient kidney care services, has received Ambulatory Health Care Accreditation from The Joint Commission.

29 Apr 2013

Baby boomers need to get tested for hepatitis C

If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. Baby boomers are five times more likely than other adults to be infected. In fact, 75 percent of adults with hepatitis C were born during these years.

29 Apr 2013

Researchers report progress on non-invasive method to assess kidney function

Researchers may have found a way to block kidney-destroying inflammation and help damaged kidney cells recover.

17 Apr 2013

Study finds racial differences in end-of-life care for patients receiving chronic dialysis

At the end of life, black patients with kidney failure receiving chronic dialysis are less likely to be referred to hospice and to discontinue dialysis compared with white patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

12 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

Study: Growth hormone therapy reverses growth problems in pediatric patients with kidney failure

Growth hormone therapy can help reverse growth problems in children with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

5 Apr 2013

FDA approves CryoLife's next generation HeRO device

CryoLife, Inc., a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration 510(k) clearance for a next generation HeRO (Hemodialysis Reliable Outflow) device.

5 Apr 2013

Diaverum acquires four clinics in Hamburg, Germany

Diaverum, one of the world's leading, product-independent renal care providers, has announced the major acquisition of the four clinics that make up the Alte Teichweg centre in Hamburg, Germany.

4 Apr 2013

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism, Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.

4 Apr 2013

Viewpoints: Time to focus on health care prices; Entitlement programs and generational warfare; Cigarette tax hikes and smoking cessation

Traditionally, the theory driving discussions on the high cost of health care in the United States has been that there is enormous waste in the system, taking the form of excess utilization of care. From that theory it follows that methods of controlling the growth of health spending should focus on ways to reduce the use of unnecessary or only marginally beneficial health care.

30 Mar 2013

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.

30 Mar 2013

Study examines dialysis survival among racial and ethnic subgroups

Among kidney failure patients on dialysis, Hispanics tend to live the longest and Whites the shortest, with Blacks' survival time in between these two, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

29 Mar 2013

Study results show trends in surgical management of patients with kidney disease

Researchers at the University of California, San Diego School of Medicine have released study results that show national treatment trends in the surgical management of patients with kidney disease.

26 Mar 2013

Dialysis News and Research

Latest Dialysis News and Research

Study shows drama therapy improves mood and reduces pain for hemodialysis patients

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Children on dialysis for severe kidney disease have reduce risk of death

Study finds disparity in live-donor kidney transplants in African Americans

Study finds decrease in mortality rates among children initiating ESKD treatment with dialysis

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Organic pollutants increase nephropathy risk in diabetes

DaVita Hospital Services receives Ambulatory Health Care Accreditation

Baby boomers need to get tested for hepatitis C

Researchers report progress on non-invasive method to assess kidney function

Study finds racial differences in end-of-life care for patients receiving chronic dialysis

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Study: Growth hormone therapy reverses growth problems in pediatric patients with kidney failure

FDA approves CryoLife's next generation HeRO device

Diaverum acquires four clinics in Hamburg, Germany

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Viewpoints: Time to focus on health care prices; Entitlement programs and generational warfare; Cigarette tax hikes and smoking cessation

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

Study examines dialysis survival among racial and ethnic subgroups

Study results show trends in surgical management of patients with kidney disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in